Cargando…
Clinicians’ Expectations for Gene-Driven Cancer Therapy
A new era of medicine is rapidly approaching, which will change not only pathological diagnosis but also medical decision-making. This paper raises the question of how well prepared doctors are to address the new issues that will soon confront them. The human genome has been completely sequenced and...
Autor principal: | Jekunen, Antti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271717/ https://www.ncbi.nlm.nih.gov/pubmed/25574148 http://dx.doi.org/10.4137/CMO.S20737 |
Ejemplares similares
-
Current challenges in applying gene-driven therapies in clinical lung cancer practice
por: Saarenheimo, Jatta, et al.
Publicado: (2021) -
Role of Rebiopsy in Relapsed Non-Small Cell Lung Cancer for Directing Oncology Treatments
por: Jekunen, Antti P.
Publicado: (2015) -
Decision-making in product portfolios of pharmaceutical research and development – managing streams of innovation in highly regulated markets
por: Jekunen, Antti
Publicado: (2014) -
Gene-Guided Treatment Decision-Making in Non-Small Cell Lung Cancer – A Systematic Review
por: Saarenheimo, Jatta, et al.
Publicado: (2021) -
The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer
por: Saarenheimo, Jatta, et al.
Publicado: (2019)